Ingrid Lafon

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 577 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

Cyrille Hulin, Thierry Façon, Philippe Rodon et al. · Journal of Clinical Oncology · 2009 · 381 citations

Medicine, Pharmacology, Pharmacotherapy +17

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Thorsten Braun, Raphaël Itzykson, Aline Renneville et al. · Blood · 2011 · 198 citations · Full text

Medicine, Oncology, Pharmacology +12

Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Laurent Garderet, Simona Iacobelli, Philippe Moreau et al. · Journal of Clinical Oncology · 2012 · 188 citations · Full text

Medicine, Hematology, Pharmacotherapy +17